Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A

被引：3

作者：

Repesse, Yohann ^{[1
,2
,3
]}

Costa, Catherine ^{[4
]}

Palla, Roberta ^{[5
]}

Moshai, Elika Farrokhi ^{[6
]}

Borel-Derlon, Annie ^{[1
,2
,3
]}

D'Oiron, Roseline ^{[7
]}

Rothschild, Chantal ^{[8
]}

El-Beshlawy, Amal ^{[9
]}

Elalfy, Mohsen ^{[10
]}

Ramanan, Vijay ^{[11
]}

Eshghi, Peyman ^{[12
]}

Oldenburg, Johannes ^{[13
]}

Pavlova, Anna ^{[13
]}

Rosendaal, Frits R. ^{[14
]}

Peyvandi, Flora ^{[5
]}

Kaveri, Srinivas V. ^{[6
]}

Lacroix-Desmazes, Sebastien ^{[6
]}

机构：

[1] CHU Caen, Hematol Lab, Caen, France

[2] INSERM, U1237, GIP Cyceron, Caen, France

[3] Normandie Univ, UNI CAEN, UFR Sante, Caen, France

[4] Grp Hosp Cochin Broca, AP HP, Hotel Dieu, Serv Genet & Biol Mol, Site Cochin, Paris, France

[5] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[6] Univ Paris Diderot, Sorbonne Univ, USPC, Ctr Rech Cordeliers,INSERM, Paris, France

[7] AP HP, Ctr Traitement Hemophilie, Le Kremlin Bicetre, France

[8] Hop Necker Enfants Malad, AP HP, Ctr Traitement Hemophilie, Paris, France

[9] Cairo Univ, Pediat Hosp, Pediat Hematol Dept, Cairo, Egypt

[10] Cairo Univ, Ain Shams Ctr, Dept Pediat, Fac Med, Cairo, Egypt

[11] Jehangir Hosp Premises, Jehangir Clin Dev Ctr, Dept Hematol, Pune, Maharashtra, India

[12] Shahid Beheshti Univ Med Sci, Pediat Congenital Hematol Disorders Res Ctr, Tehran, Iran

[13] Univ Clin Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany

[14] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands

来源：

HAEMATOLOGICA | 2019年 / 104卷 / 08期

关键词：

COAGULATION FACTOR-VIII; VONWILLEBRAND-FACTOR; FACTOR GENE; POLYMORPHISMS; MUTATIONS; IMMUNOGENICITY; ANTIBODIES; FVIII;

D O I：

10.3324/haematol.2018.212001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E369 / E372

页数：4

共 50 条

[31] IMPACT OF ANEMIA ON VON WILLEBRAND FACTOR AND FACTOR VIII IN TYPE 1 VON WILLEBRAND DISEASE AND MILD HEMOPHILIA
Febres, Maria E. Carter
Tarango, Cristina
Fenchel, Matthew
Pomales, Jennifer
Mullins, Eric
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E18 - E18
[32] Identifying the role of Factor VIII and Von Willebrand factor in multiple sclerosis
Roy, D. B.
Shi, K.
Shi, F-D
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 449 - 450
[33] Inhibitors of Factor VIII in Black Patients with Hemophilia
Viel, Kevin R.
Ameri, Afshin
Abshire, Thomas C.
Iyer, Rathi V.
Watts, Raymond G.
Lutcher, Charles
Channell, Cynthia
Cole, Shelley A.
Fernstrom, Karl M.
Nakaya, Shelley
Kasper, Carol K.
Thompson, Arthur R.
Almasy, Laura
Howard, Tom E.
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (16): : 1618 - 1627
[34] Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States
Neufeld, Ellis J.
Sidonio, Robert F., Jr.
O'Day, Ken
Runken, M. Chris
Meyer, Kellie
Spears, Jeffrey
JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (08) : 762 - 769
[35] Factor VIII Products and Inhibitors in Severe Hemophilia A REPLY
van den Berg, H. Marijke
Gouw, Samantha C.
van der Bom, Johanna G.
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (15): : 1457 - 1457
[36] Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivo
Shi, Q.
Kuether, E. L.
Schroeder, J. A.
Perry, C. L.
Fahs, S. A.
Gill, J. Cox
Montgomery, R. R.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (11) : 2328 - 2337
[37] Factor VIII Inhibitors: Von Willebrand Factor Makes A Difference In Vitro and In Vivo
Shi, Qizhen
Kuether, Erin L.
Schroeder, Jocelyn A.
Perry, Crystal L.
Fahs, Scot A.
Montgomery, Robert R.
BLOOD, 2010, 116 (21) : 313 - 313
[38] von Willebrand factor containing factor VIII concentrates
Berntorp, E
HAEMOPHILIA, 1999, 5 : 60 - 63
[39] Von Willebrand Factor and factor VIII inhibitor testing
Siegemund, T.
Scholz, U.
Siegemund, A.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 839 - 839
[40] von Willebrand factor in factor VIII concentrates protects against neutralization by factor VIII antibodies of haemophilia A patients
Kallas, A
Talpsep, T
HAEMOPHILIA, 2001, 7 (04) : 375 - 380

← 1 2 3 4 5 →